Evaluating the Clinical Utility of Circulating Tumor Cells in Metastatic Breast Cancer-Is Not Worse Good Enough?
| Errataetall: |
CommentOn: JAMA Oncol. 2021 Jan 1;7(1):34-41. - PMID 33151266 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
|---|---|
| Enthalten in: |
JAMA oncology - 7(2021), 1 vom: 01. Jan., Seite 30-31 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ballinger, Tarah J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 10.03.2022 Date Revised 10.03.2022 published: Print CommentOn: JAMA Oncol. 2021 Jan 1;7(1):34-41. - PMID 33151266 Citation Status MEDLINE |
|---|
| doi: |
10.1001/jamaoncol.2020.5460 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM317194232 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM317194232 | ||
| 003 | DE-627 | ||
| 005 | 20231225162726.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1001/jamaoncol.2020.5460 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1057.xml |
| 035 | |a (DE-627)NLM317194232 | ||
| 035 | |a (NLM)33151269 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ballinger, Tarah J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Evaluating the Clinical Utility of Circulating Tumor Cells in Metastatic Breast Cancer-Is Not Worse Good Enough? |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.03.2022 | ||
| 500 | |a Date Revised 10.03.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: JAMA Oncol. 2021 Jan 1;7(1):34-41. - PMID 33151266 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Receptor, ErbB-2 |2 NLM | |
| 650 | 7 | |a EC 2.7.10.1 |2 NLM | |
| 700 | 1 | |a Smith, Mary Lou |e verfasserin |4 aut | |
| 700 | 1 | |a Miller, Kathy D |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t JAMA oncology |d 2015 |g 7(2021), 1 vom: 01. Jan., Seite 30-31 |w (DE-627)NLM250070588 |x 2374-2445 |7 nnns |
| 773 | 1 | 8 | |g volume:7 |g year:2021 |g number:1 |g day:01 |g month:01 |g pages:30-31 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1001/jamaoncol.2020.5460 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 7 |j 2021 |e 1 |b 01 |c 01 |h 30-31 | ||